Topical corticosteroids in seborrhoeic dermatitis. A report from The General Practitioner Research Group.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007509:Irritants; D008297:Male; D008875:Middle Aged
D000893:Anti-Inflammatory Agents; D007509:Irritants; C007975:hydrocortisone-17-butyrate; D001623:Betamethasone; D001624:Betamethasone Valerate; D006854:Hydrocortisone